Dolutegravir (Pediatric)

An Integrase Strand Transfer Inhibitor (INSTI). It has a high genetic barrier to resistance and is now the WHO-preferred first-line treatment for children.

Dosage by Body Weight

Dispersible tablets (5mg) are used for infants/children from 3kg and 4 weeks of age. Can be dissolved in water.

Body Weight
3-6 kg
Dose
5 mg
Frequency
Once daily
Tracking Notes
Preferred 5mg dispersible tablet for infants.
Body Weight
14-20 kg
Dose
25 mg
Frequency
Once daily
Tracking Notes
Can be taken with or without food.

Weight-based dosage tracking table for Dolutegravir (Pediatric), including body weight, dose, frequency, and tracking notes.
Body Weight	Dose	Frequency	Tracking Notes
3-6 kg	5 mg	Once daily	Preferred 5mg dispersible tablet for infants.
14-20 kg	25 mg	Once daily	Can be taken with or without food.

Formulation

Dispersible TabletTablet

Purpose

First-line antiretroviral treatment for HIV-1.

Generic Name

Dolutegravir (DTG)

Branded Drug Names

Dolutegravir (Pediatric) is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:

Tivicay
Instgra

Scheduled Drug

Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.

Alternatives

RaltegravirEfavirenz